|Outsourcing Outlook Jim MillerCMC Development is Hot|
Ingredients Insider Cynthia ChallenerConjugation Chemistry with Highly Potent Compounds
|Regulatory Watch Jill Wechsler Vaccine Development Faces Urgency and Challenges|
|EU Regulatory Watch Sean Milmo Europe Moves Forward on Anticounterfeiting Meaures|
With deadlines only a few years away, some companies have not started serialization programs, while others are taking a tactical, short-term approach, losing out on potential business benefits.
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses how to report quality metrics to FDA.
Growth may be slowing, but outsourcing activity remains healthy.